Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting
- PMID: 8916486
- DOI: 10.1016/s0002-9149(96)00532-2
Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting
Abstract
This prospective nonrandomized study was performed comparing aspirin alone (n = 46) versus aspirin and ticlopidine (p = 338) following native coronary artery stenting. There were significantly more stent thrombosis events in the aspirin-only group than in the aspirin and ticlopidine group (6.5% vs 0.9%, p = 0.02) and significantly more Q-wave myocardial infarctions and cardiac-related deaths in the aspirin-only group than in the aspirin and ticlopidine group (6.5% vs 0%, p = 0.002 and 4.4% vs 0.3% p = 0.02, respectively).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
